S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions

FibroGen (FGEN) News Today

$0.62
0.00 (0.00%)
(As of 12/8/2023 ET)
Compare
Today's Range
$0.59
$0.65
50-Day Range
$0.38
$0.81
52-Week Range
$0.33
$25.69
Volume
774,248 shs
Average Volume
1.88 million shs
Market Capitalization
$60.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00
SourceHeadline
finance.yahoo.com logoFibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meeting
finance.yahoo.com - December 9 at 5:54 PM
MarketBeat logoFibroGen (NASDAQ:FGEN) Coverage Initiated at StockNews.com
americanbankingnews.com - December 8 at 1:20 AM
sg.finance.yahoo.com logoFibroGen, Inc. (FGEN) stock price, news, quote & history – Yahoo Finance
sg.finance.yahoo.com - December 4 at 9:31 AM
MarketBeat logoFibroGen, Inc. (NASDAQ:FGEN) Receives Consensus Recommendation of "Reduce" from Analysts
americanbankingnews.com - November 30 at 2:16 AM
MarketBeat logoFibroGen (NASDAQ:FGEN) Now Covered by StockNews.com
americanbankingnews.com - November 30 at 1:30 AM
morningstar.com logoFibroGen Inc FGEN
morningstar.com - November 11 at 3:35 PM
finance.yahoo.com logoFibroGen, Inc. (NASDAQ:FGEN) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 7 at 3:51 PM
finance.yahoo.com logoFibroGen (FGEN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
finance.yahoo.com - November 6 at 9:43 PM
finance.yahoo.com logoFibroGen Inc (FGEN) Reports 155% YoY Increase in Q3 2023 Net Revenue
finance.yahoo.com - November 6 at 9:43 PM
finance.yahoo.com logoFibroGen Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 6 at 4:43 PM
markets.businessinsider.com logoFibroGen earnings: here's what Wall Street expects
markets.businessinsider.com - November 5 at 10:41 AM
barrons.com logoBronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Fibrogen, Inc. (FGEN) Investigation
barrons.com - October 29 at 2:05 PM
finance.yahoo.com logoFibroGen to Report Third Quarter 2023 Financial Results
finance.yahoo.com - October 23 at 9:28 AM
markets.businessinsider.com logoFibroGen's Pamrevlumab Doesn't Meet Goals In Phase III LELANTOS-2 Trial; Stock Down In Pre-market
markets.businessinsider.com - August 30 at 11:15 AM
markets.businessinsider.com logoThree In A Row: FibroGen's Investigational Drug Flunks In Another Study For Rare Disease In Young Boys
markets.businessinsider.com - August 30 at 11:15 AM
proactiveinvestors.com logoFibroGen stock plummets as muscular dystrophy drug trial fails
proactiveinvestors.com - August 30 at 11:15 AM
msn.com logoFibroGen (NASDAQ: FGEN) Tumbles after Setback in Phase 3 DMD Trial
msn.com - August 30 at 11:15 AM
marketwatch.com logoStocks to Watch: FibroGen, Box
marketwatch.com - August 29 at 11:12 PM
finance.yahoo.com logoFibroGen's drug misses mark on yet another clinical trial
finance.yahoo.com - August 29 at 11:12 PM
marketwatch.com logoFibroGen Shares Sink 16% on Pamrevlumab Study Not Meeting Primary Endpoint
marketwatch.com - August 29 at 6:11 PM
msn.com logoFibroGen stock tumbles on failed Phase 3 study for muscular dystrophy drug
msn.com - August 29 at 6:11 PM
finance.yahoo.com logoFibroGen Announces Topline Results from LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Ambulatory Duchenne Muscular Dystrophy
finance.yahoo.com - August 29 at 6:11 PM
marketbeat.com logoFibroGen, Inc. (NASDAQ:FGEN) Receives Consensus Rating of "Reduce" from Analysts
marketbeat.com - August 22 at 4:37 AM
finance.yahoo.com logoDown -46.88% in 4 Weeks, Here's Why FibroGen (FGEN) Looks Ripe for a Turnaround
finance.yahoo.com - August 16 at 5:06 PM
marketbeat.com logoQ3 2023 Earnings Forecast for FibroGen, Inc. Issued By William Blair (NASDAQ:FGEN)
marketbeat.com - August 10 at 7:44 AM
finance.yahoo.com logoIs There An Opportunity With FibroGen, Inc.'s (NASDAQ:FGEN) 42% Undervaluation?
finance.yahoo.com - August 9 at 11:15 AM
finance.yahoo.com logoFibroGen Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 9 at 12:49 AM
msn.com logoB of A Securities Downgrades FibroGen (FGEN)
msn.com - August 8 at 7:49 PM
markets.businessinsider.com logoExpert Ratings for FibroGen
markets.businessinsider.com - August 8 at 2:49 PM
seekingalpha.com logoFibroGen Q2 2023 Earnings Preview
seekingalpha.com - August 8 at 9:48 AM
finance.yahoo.com logoFibroGen (FGEN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
finance.yahoo.com - August 8 at 9:48 AM
finance.yahoo.com logoFibroGen, Inc. (NASDAQ:FGEN) Q2 2023 Earnings Call Transcript
finance.yahoo.com - August 8 at 9:48 AM
marketbeat.com logoFibroGen (NASDAQ:FGEN) Downgraded to Underperform at Bank of America
marketbeat.com - August 8 at 7:14 AM
marketbeat.com logoJump Financial LLC Buys Shares of 54,174 FibroGen, Inc. (NASDAQ:FGEN)
marketbeat.com - August 3 at 5:38 AM
bizjournals.com logoSan FranciscoBusiness Times
bizjournals.com - July 31 at 4:08 PM
marketbeat.com logoIntercontinental Wealth Advisors LLC Sells 95,650 Shares of FibroGen, Inc. (NASDAQ:FGEN)
marketbeat.com - July 29 at 12:31 AM
marketbeat.com logoFibroGen, Inc. (NASDAQ:FGEN) Given Average Recommendation of "Reduce" by Brokerages
marketbeat.com - July 28 at 3:49 AM
finance.yahoo.com logoFibroGen CEO resigns after back-to-back drug study failures, job cuts
finance.yahoo.com - July 25 at 3:44 PM
finanznachrichten.de logoFibroGen, Inc.: FibroGen Announces Leadership Transition
finanznachrichten.de - July 25 at 10:43 AM
finance.yahoo.com logoFibroGen Announces Leadership Transition
finance.yahoo.com - July 25 at 10:43 AM
finance.yahoo.com logoFibroGen to Report Second Quarter 2023 Financial Results
finance.yahoo.com - July 24 at 8:25 AM
marketbeat.com logoState of New Jersey Common Pension Fund D Sells 60,739 Shares of FibroGen, Inc. (NASDAQ:FGEN)
marketbeat.com - July 23 at 4:33 AM
msn.com logoSF biotech company FibroGen laying off nearly a third of its workers
msn.com - July 20 at 8:49 AM
bizjournals.com logoPioneering Mission Bay biotech company Fibrogen to cut more than 100 jobs
bizjournals.com - July 19 at 12:27 PM
finance.yahoo.com logoFibroGen (FGEN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
finance.yahoo.com - July 14 at 1:07 PM
finance.yahoo.com logoDown -83.78% in 4 Weeks, Here's Why FibroGen (FGEN) Looks Ripe for a Turnaround
finance.yahoo.com - July 11 at 3:36 PM
marketbeat.com logoAllspring Global Investments Holdings LLC Grows Stock Holdings in FibroGen, Inc. (NASDAQ:FGEN)
marketbeat.com - July 10 at 4:20 AM
msn.com logoFibroGen (FGEN) Price Target Decreased by 67.57% to 8.16
msn.com - July 6 at 3:32 PM
finance.yahoo.com logoDown 80% in 1 Day, Is There Any Hope for FibroGen Stock?
finance.yahoo.com - July 1 at 9:10 AM
marketbeat.com logo1,344,583 Shares in FibroGen, Inc. (NASDAQ:FGEN) Bought by Assenagon Asset Management S.A.
marketbeat.com - June 30 at 6:30 AM
Get FibroGen News Delivered to You Automatically

Sign up to receive the latest news and ratings for FGEN and its competitors with MarketBeat's FREE daily newsletter.



FGEN Media Mentions By Week

FGEN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FGEN
News Sentiment

-0.37

0.52

Average
Medical
News Sentiment

FGEN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FGEN Articles
This Week

3

2

FGEN Articles
Average Week

Get FibroGen News Delivered to You Automatically

Sign up to receive the latest news and ratings for FGEN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:FGEN) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -